Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Biliary tract cancer”
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
ClinicalTrials.gov study NCT04720131. IPD Sharing: UNDECIDED. Countries: 1. Publications: 17.
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
ClinicalTrials.gov study NCT02829918. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
ClinicalTrials.gov study NCT00361231. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT02711553. IPD Sharing: YES. Countries: 18. Publications: 1.
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
ClinicalTrials.gov study NCT04072445. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04677504. IPD Sharing: YES. Countries: 13. Publications: 2.
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01679405. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT03785873. IPD Sharing: YES. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT03768414. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)
ClinicalTrials.gov study NCT00661830. IPD Sharing: Not stated. Countries: 1. Publications: 1.
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
ClinicalTrials.gov study NCT03833661. IPD Sharing: YES. Countries: 9. Publications: 3.
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
ClinicalTrials.gov study NCT00107536. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00753675. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
ClinicalTrials.gov study NCT03101566. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
ClinicalTrials.gov study NCT01943864. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
ClinicalTrials.gov study NCT04466891. IPD Sharing: YES. Countries: 9. Publications: 2.
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04163900. IPD Sharing: NO. Countries: 15. Publications: 2.
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
ClinicalTrials.gov study NCT03875235. IPD Sharing: YES. Countries: 17. Publications: 5.
Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy
ClinicalTrials.gov study NCT02579616. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
ClinicalTrials.gov study NCT02443324. IPD Sharing: Not stated. Countries: 6. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.